Children and adolescents with obesity have lower levels of serum catestatin — an endogenous peptide found to be negatively associated with blood pressure level and insulin resistance — compared with children and adolescents with normal weight, according to findings published in Pediatric Diabetes.
Source: Serum catestatin may predict metabolic, CV risk in children, adolescents